Olfactory bulb agenesis, hypoplasias, and dysplasias

Harvey B Sarnat MS MD FRCPC

General Neurology

Updated 05.26.2024
Released 07.07.1997
Expires For CME 05.26.2027

Olfactory bulb agenesis, hypoplasias, and dysplasias

Author: Harvey B Sarnat MS MD FRCPC

See Contributor Disclosures

Olfactory bulb agenesis, hypoplasias, and dysplasias

In This Article

Quick Link

Introduction

Overview

In this article, the author describes olfactory bulb agenesis and dysgenesis and also reviews the embryology, maturation, neuropathology, and clinical diagnosis and manifestations. The olfactory bulb is still immature but functional in the term neonate. It is a reservoir of progenitor “stem” cells capable of neuronal differentiation in the adult as well as in the fetus. Complete agenesis of the olfactory tract results in congenital anosmia. Olfactory reflexes in the neonate and preterm infant can be tested as early as 28 weeks’ gestation using a nonirritant aromatic substance, such as peppermint (infantile olfactory reflexes). Fetuses perceive odors in the amniotic fluid that circulate through the nasal passages in the late second and third trimesters. Agenesis of the olfactory bulbs (arrhinencephaly) is a constant feature in alobar and semilobar holoprosencephaly but also can occur as an isolated minor cerebral malformation without other dysgeneses. At times it is asymmetrical. In septo-optic-pituitary dysplasia the olfactory bulbs often are hypoplastic. In Kallmann syndrome, there is hypogonadism with delayed or absent puberty; associated neurologic findings may be present, such as ataxia, impaired hearing, eye movement disorders, or mental handicap. Diagnosis is confirmed by MRI, and molecular studies can reveal genetic mutations. Dysgenesis, rather than agenesis, of the histological architecture of the olfactory bulbs and synaptic circuitry occurs in some genetic syndromes, such as fragile X, and particularly in postzygotic somatic mutations including tuberous sclerosis complex, hemimegalencephaly, and focal cortical dysplasia type II. Multiple genetic factors are essential in normal olfactory bulb ontogenesis. Supernumerary olfactory bulbs are rarer than agenesis but documented and associated with impaired olfaction. Fusion of olfactory bulbs may occur in some cases in which the bulb appears unilaterally absent on gross examination.

Key points

	• Agenesis of the olfactory bulbs (arrhinencephaly) may occur as an isolated defect, as a component of holoprosencephaly (regardless of the genetic etiology) associated with other cerebral malformations, or as a component of Kallmann syndrome with endocrinopathies.
	• Agenesis or hypoplasia of one or both olfactory bulbs at times occurs in isolation without other CNS anomalies or with other focal defects such as hypoplasia of the ipsilateral optic nerve and in septo-optic-pituitary dysplasia.
	• The clinical feature is anosmia, but patients rarely complain of this because it is congenital rather than acquired after they had experienced a sense of smell; the deficit is nonprogressive.
	• It can be diagnosed by MRI of the olfactory bulbs following clinical demonstration of absent olfaction bilaterally; neuropathological confirmation is demonstrated at autopsy, though olfactory agenesis is not a cause of death.
	• Olfactory reflexes are present at birth (after 32 weeks gestation) and can be tested as part of the neurologic exam in neonates and young infants by using an aromatic, non-irritative test substance that does not stimulate the pain endings of the trigeminal nerve in the nasal mucosa; responses are sucking or arousal withdrawal.
	• Olfactory thresholds are determined in part by specific receptors of primary olfactory neurons in the nasal mucosa.
	• The principal well-documented olfactory dysplasias are the presence of a deep longitudinal sulcus on the inferior surface with synaptic glomeruli lining the neural tissue on either side (hemimegalencephaly), megalocytic and dysplastic neurons (tuberous sclerosis and hemimegalencephaly), fusion of the two olfactory bulbs, and delayed maturation of expression of neuronal proteins and synapse formation.
	• Olfactory bulb agenesis should be distinguished from acquired causes of anosmia, such as fracture of the cribriform plate in head trauma, tumors, granulomas and other lesions of the olfactory bulbs or tracts, olfactory groove meningioma, vascular anomalies associated with a persistent fetal olfactory artery, and olfactory impairment due to chemotherapy or other drugs.
	• Multiple genetic mutations and deficiencies of transcription factors and cell adhesion molecules are associated with olfactory agenesis, but usually with other CNS anomalies.
	• Supernumerary olfactory bulbs occur rarely.
	• Some olfactory auras in focal epilepsy may originate in the olfactory bulb and can only be mediated by the amygdala, insula, or entorhinal cortex.
	• Impaired olfaction and olfactory nerve and bulb agenesis may accompany nasal and facial clefts, choanal atresia, and other nasofacial anomalies.
	• Olfaction often is impaired in some infections such as COVID-19, influenza, and cytomegalovirus.

Historical note and terminology

Perception of odorous soluble molecules is the earliest special sense to develop both phylogenetically and ontogenetically. Even simple medusae (jellyfish) and polyps (hydra) that poses only a simple nerve net without a brain or even a ganglion can perceive and distinguish molecules in surrounding sea water as attractants (ie, food) or adversive elements (ie, potentially harmful) and react accordingly, as noted as early as 1849 by the famous English biologist of his era, Thomas Huxley (91). Human fetuses also perceive odors dissolved in amniotic fluid. Whether these primitive perceptions are best classified as olfactory or gustatory (taste) is a difficult distinction. Both fetuses and preterm neonates distinguish different types of both pleasant and unpleasant odors (122; 187; 201; 136; 200).

The cranial nerves were numbered I to XII by Sömmerring in 1791, but the human olfactory nerve had been described half a century earlier by Winslow in 1733. In ancient times Alcmaeon of Croton (c490-430 B.C.), the father of Greek medicine, first postulated that “channels” (ie, passages, ducts) connected sense organs of the head (nose, eyes, ears, tongue) with the brain, and he is attributed to have first described the olfactory and optic nerves, as reported by Aristotle’s successor Theophrastus (c327-287 B.C.) and later also acknowledged by Galen in the 2nd century A.D. (217).

The first report of anosmia associated with hypogonadism was in 1856 (130). In 1918 Blakeslee described specific anosmia for either pale pink or red verbenas, but not for both, in a group of healthy people (30), and a few reports have since appeared describing familial congenital anosmia in otherwise mainly asymptomatic people (132; 127; 209). In addition, there have been occasional descriptions of "sporadic cases of Kallmann syndrome," in which isolated congenital anosmia is also present (85). In a seminal paper on the genetic aspects of primary eunuchoidism, Fritz Kallmann and colleagues described 36 males and 12 females in whom the condition was associated with combinations of anosmia, color blindness, synkinesis, and mental handicap (96). Subsequent clinical descriptions have permitted better delineation of the syndrome and its association with aplasia or hypoplasia of the olfactory bulbs and tracts (211; 134; 238; 85). A study that investigated isolated congenital anosmia without chromosomal disorders (02) compared the MRI appearances of the frontobasal structures of 16 patients with controls. In half the patients there was bilateral hypoplasia of the olfactory bulbs, and in the remainder there were combinations of hypoplasia and aplasia of the bulbs. Descriptions of anosmia and olfactory aplasia as one component of the holoprosencephalies represent the other extreme of the spectrum (74; 124). Isolation of the Kallmann syndrome gene in X-linked Kallmann syndrome has expanded our insight into this syndrome of anosmia and hypogonadism (125; 166). Septo-optic-pituitary dysplasia is a frequent cerebral malformation and is often accompanied by olfactory bulb hypoplasia or even aplasia (196; 24).

Olfaction and taste are functionally closely related despite the wide separation of their neuroanatomical receptive centers in the olfactory bulb and lower brainstem, respectively (190). Even the simplest marine animals with only a primitive nerve network and no central nervous system, such as medusa (jellyfish) and polyps (hydra, sea anemones, etc.), perceive molecules dissolved in the water as either threatening, resulting in retraction of tentacles, or food, resulting in feeding behaviors. In humans, postnatal respiration is essential for smell, and retronasal olfaction is dependent on expiration and also refines perception of taste for chocolate and other flavors, even accompanied by EEG changes (138). Olfaction is an important aspect of wine tasting and distinguishing foods.

There are no published consensus criteria of the definition of a “cranial nerve.” The following is a suggested working definition for sensory cranial nerves: (a) peripheral nerves; (b) arising from neurons in the peripheral nervous system that possess dendritic receptors for specific sensory stimuli; (c) include a ganglion at some point along the nerve (eg, trigeminal gasserian, semilunar ganglion, facial geniculate ganglion, vestibular/cochlear spiral ganglion, glossopharyngeal jugular or Müller ganglion, vagal jugular, nodose ganglion); and (d) enter the brain, not the spinal cord (194). By these simple criteria, the olfactory is a true cranial nerve, even though its dispersed axons do not become compacted until they reach the olfactory bulb to form layer one of this structure. Though the olfactory nerve lacks a compact ganglion along its course, unique synaptic glomeruli on the ventral surface of the olfactory bulb, facing the cribriform plate of the ethmoid bone through which individual olfactory nerve fibres pass, are connections between primary olfactory axons and dendrites of mitral and tufted cells (190); these glomeruli serve the same function, hence, an olfactory ganglionic equivalent is incorporated into the olfactory bulb as layer two of the bulb (194). Ironically, the accessory olfactory bulb, a transitory fetal structure in humans, has peripheral ganglia like those of other sensory cranial nerves but lacks synaptic glomeruli because it is fused to the principal olfactory bulb far from the cribriform plate because the accessory bulb is fused to the principal olfactory bulb dorso-medially far from the cribriform plate (174; 175). Many residents and attending pediatric neurologists hold the premise that the olfactory nerve is not a “true” cranial nerve, but objective neuroanatomical criteria dispel this unjustified notion in comparing the olfactory with lower sensory cranial nerves. The olfactory bulb and tract are still immature at birth with incomplete synaptogenesis and no myelination, yet already are functional to perceive olfaction from about 28 weeks’ gestation.

Apart from genetic mutations and ischemic infarction from congenital infections, embryonic or fetal exposure to certain teratogens or toxins (for example, arsenic) can interfere with olfactory neuronal differentiation, synapse formation, and result in impaired olfactory perception even into adult life (218).

Clinical manifestations

Presentation and course

Despite the ease and reliability of testing in infants and children, regrettably cranial nerve I is the least clinically tested cranial nerve in neonates and at older ages by clinicians, even in cases of cerebral malformations or genetic/metabolic diseases in which its smell is likely to be impaired or absent (195). Similarly, radiologists inconstantly describe the olfactory bulbs and tracts in MRI reports, and neuropathologists usually mention their macroscopic presence or absence at autopsy but rarely take blocks of this part of the brain for microscopic examination. Thus, neuropathological reports of olfactory dysgenesis are infrequent (190).

Congenital anosmia as an isolated clinical entity will probably be discovered only by chance during childhood or early adult life and be confirmed by conventional testing (49). Awareness of a positive family history may bring it to light sooner. A limited number of such kindreds have been published (132; 127; 209), and they did not have any relevant associated symptoms. These reports all predated MRI scanning, and there were no reported autopsies, so it is not known whether the olfactory bulbs and tracts were present or absent. Children with apparently isolated congenital anosmia can be demonstrated by MRI to have bilateral aplasia of the olfactory bulbs (15; 185). Unilateral olfactory bulb hypoplasia also can be shown.

Focal hypoplasia of the olfactory bulb and tract

Axial T2-weighted MRI of a 7-year-old girl with focal hypoplasia of the left olfactory bulb and tract. She also has left optic nerve hypoplasia (not shown). The right olfactory bulb and the optic nerve are of expected size and app...

Functional MRI studies of congenital hyposmia compared with normal subjects and others with acquired hyposmia have shown that brain activation was present in response to odors in congenital hyposmia; although lower than normal, the distribution was similar to the other (83). Some anosmia is specific or partial; otherwise, normal subjects are unable to perceive certain smells, with musk, sweat, hydrogen cyanide, trimethylamine, and isovaleric acid being the more common. A survey carried out by the National Geographic magazine on 1.5 million people in 1986 found that 35% could not smell sweat, 29% could not perceive musk, and 13% were unable to smell either (77; 78). More commonly, olfactory aplasia with anosmia is part of Kallmann syndrome and associated with a deficiency of gonadotropic-releasing hormone due to a failure of migration of GnRH precursors that should be initiated by intact olfactory axons (50). Kallmann syndrome is one manifestation of the arrhinencephaly spectrum; therefore, more widespread evidence of migration failures such as the holoprosencephalies and other developmental anomalies may sometimes be present (58; 124).

An intrinsic vasopressin system in the olfactory bulb also is demonstrated as a peptide that may be defective in olfactory bulb agenesis; vasopressin appears to be involved in social recognition in addition to its functions in autonomic control of blood vessels (222). Regarding olfaction and cognitive functions, patients with schizophrenia have a higher than expected incidence of olfactory defects, both structural (such as olfactory bulb hypoplasia or agenesis) and strictly functional (226; 183). Olfactory bulb dysgenesis also can be associated with infantile autism and autonomic dysregulation (35).

A contribution from the trigeminal system in some confirmed cases of Kallmann syndrome indicates that there can be a certain ability to distinguish some odorants such as menthol, eucalyptus and alcohol (114). Clinical suspicion of Kallmann syndrome should be present in any case of delayed puberty (particularly in males), although the extent of the delay can vary from extremes of absent or minimal pubertal development to normal gonadal function. This should lead to standard testing of the sense of smell. If this is absent, a review for any possible associated anomalies should be undertaken. Olfactory bulb hypoplasias or agenesis, associated with hyposmia, is frequent in hypogonadotropic hypogonadism (57). Neurologic associations in some, but not all, cases include congenital midline cerebral and cerebellar defects, especially agenesis of the corpus callosum and vermal hamartomas. Neurologic findings are inconsistent and include cerebellar ataxia (which may be a presenting sign), eye movement abnormalities including nystagmus, spasticity, synkinesis, and mental retardation (204; 182). The X-linked form may be associated with renal abnormalities; another variant of Kallmann syndrome associated with X-linked ichthyosis, mental retardation, and short stature has been described (215). Other reported findings include color blindness (96), sensorineural hearing loss (238), cleft lip and palate (211), insulin-dependent diabetes mellitus, and congenital heart disease (48). Associations with anorexia nervosa, cardiomyopathy, and ulcerative colitis have also been reported.

Patients with schizophrenia have impaired olfactory perception and olfactory habituation, particularly in patients with olfactory hallucinations (212). The mechanism may be related to abnormal proteoglycans in the olfactory epithelium (156). The principal proteoglycan of brain is keratan sulfate, which provides a template for axonal fascicles and neuroblast migratory pathways, and is normally strongly expressed in primary olfactory nerve axons that form the outer layer of the fetal olfactory bulb and enter olfactory bulb synaptic glomeruli (198). Low olfactory bulb volume also is described in first-degree relatives of patients with schizophrenia (227).

Olfactory perceptive abnormalities also are reported in anxiety and in obsessive-compulsive disorders (46; 97). Haploinsufficiency of the causative Tbr1 gene of autism in mice impairs olfactory discrimination (88). In humans with haploinsufficiency (campomelic dysplasia due to SOX9 mutation), agenesis of the olfactory bulbs often is associated (52).

Supernumerary olfactory bulbs are much rarer than olfactory bulb hypoplasia or agenesis, but the bulbs can be duplicated or even triplicated, associated with abnormal olfactory groove morphology and clinical hyposmia (118). Though the precise genetic defect is not yet known, duplication of structures is associated with upregulation of a gene in the vertical axis of the neural tube and, in the case of the olfactory bulb, a gene following a ventrodorsal gradient of expression (189).

Agenesis of the olfactory bulbs was described in a twin in whom the heart had failed to develop; the brain in this case showed abnormal convolutions and an accelerated development of cortical gyration (241). In general, an association of olfactory bulb hypoplasia or agenesis is found in infants with congenital heart diseases (155).

The primitive olfactory artery originates at the terminal portion of the internal carotid artery in the fetus during the first half of gestation but may persist even into adult life and, rarely, forms an aneurysm associated with an anterior communicating aneurysm that can be successfully treated surgically if diagnosed by MRA or angiography (243).

Prognosis and complications

There are no progressive features to the condition, so in a majority a normal life span can be anticipated. If olfactory agenesis is associated with a multisystemic genetic syndrome such as CHARGE, however, the prognosis may depend on other organ involvement such as congenital cardiac lesions.

A description of a variant from of Kallmann syndrome, in which endogenous gonadotrophin secretion spontaneously returned later in life, suggests that recovery is possible in some (170).

Biological basis

Etiology and pathogenesis

Kallmann syndrome. Kallmann syndrome is a genetic disorder that may be X-linked or inherited as an autosomal disorder, which can be either dominant or recessive. Research suggests that the majority of familial cases of Kallmann syndrome are autosomal in type and that the X-linked form occurs in less than 15% (206; 153). Olfactory dysfunction was reported in 15 of 19 patients with isolated congenital hypogonadotropic hypogonadism, often associated with hypoplastic olfactory bulbs by MRI (110). See the article on Kallmann syndrome for more details.

CHARGE syndrome. CHARGE syndrome (coloboma of the iris, congenital heart disease, choanal atresia, developmental delay, genital hypoplasia, growth restriction, ear malformations and impaired hearing) is associated with anosmia and olfactory bulb hypoplasia and many features of the Kallmann syndrome (161; 10). A murine model of CHARGE syndrome of humans presents with a defect in neural stem cell proliferation and olfaction in the presence of a genetic defect in the chromodomain gene Chd7, and this same mutation may explain some human cases (115). In human CHARGE syndrome, rhinencephalic anomalies are another major criterion of this genetic syndrome and olfaction should be tested in patients in whom this diagnosis is made (41).

Children with idiopathic hypogonadotropic hypogonadism exhibit a broad spectrum of olfactory function with hypo-osmia or anosmia in one third, suggesting a pathophysiological overlap with Kallmann syndrome (119). Holoprosencephaly is a complex malformation generally detected at birth that is associated with absence of the olfactory bulbs and tracts, except in the mildest forms. The etiology is usually genetic, but more than 14 genes are now documented that produce the same or very similar phenotypes and do not predict the severity of the tissue dysmorphology.

Fragile X syndrome is another genetic disease with almost constant impairment of olfaction and also is the most frequent inherited form of cognitive/intellectual deficiency. It is caused by the FMR1 gene that encodes an important RNA-binding protein, FMRP, which regulates expression of multiple synaptic proteins (32). An animal model of fragile-X syndrome, the Fmr1 knockout mouse, exhibits impaired odor discrimination and hyperexcitability of the olfactory bulb (112).

In adult neurodegenerative characterized clinically by dementia, olfaction is nearly always impaired (244).

Ontogenesis. The olfactory bulbs form at 41 days' gestation in the human, shortly after prosencephalic cleavage with the formation of the sagittal interhemispheric fissure that creates paired telencephalic hemispheres. Axons from neurons in the primitive nasal olfactory epithelium extend to the olfactory placode in the rostrocaudal part of the early telencephalic hemisphere before this placode is even differentiated into the olfactory bulb (14). After olfactory bulb development, an olfactory recess extends from the ventrofrontal part of the lateral ventricle into it but is a transitory structure (190). It regresses and leaves clusters of ependymal cells and microcysts in the postnatal period, similar to the central canal of the spinal cord, and these remnants can be demonstrated by neuroimaging and neuropathologically even in the adult olfactory bulb (210). An accessory olfactory bulb and its associated vomeronasal organ and nervus terminalis (cranial nerve 0) are an important supplementary olfactory system in many lower vertebrates, believed to be functional during mating, but are only transitory structures in embryonic and early fetal life in humans (191). Odor recognition depends on the binding of an odorant molecule to a human odorant receptor on primary olfactory neurons; such receptors, such as OR5IE2, often are bound to the fatty acid propionate for receptor activation; one of two large families of G-protein-coupled odorant receptors or trace amine receptors that enable olfactory perception (29; 81).

In the fetus, neuroblasts of the olfactory bulb do not originate within the bulb, but stream into it from the periventricular region of the lateral ventricle and especially the lateral ganglionic eminence with secondary radial migration within the olfactory bulb (106; 181; 123). The lateral ganglionic eminence is particularly the source of inhibitory interneurons of the olfactory bulb (34), though some are produced throughout life by intrinsic progenitor cells within the olfactory bulb (235). Though the olfactory bulb was long thought to achieve maturity by 11 weeks’ gestation in terms of histological identification and arrangement of the neuronal architecture (90), studies of immunocytochemical expression of neuronal proteins and transmitters, synaptogenesis, myelination, and persistence of the olfactory ventricular recess at birth demonstrate that the human olfactory bulb is far from mature at term, even if functional in part (100; 190; 190; 193). This immaturity is incomplete synaptogenesis and myelination. In the rat, synaptophysin and synaptoporin (molecular components of synaptic vesicle membranes regardless of the transmitter contained within the vesicles) is similar in late fetal, postnatal, and adult animals in mitral and tufted neurons of the olfactory bulb, but biosynthesis of these glycoproteins by granule and periglomerular neurons occurs mainly postnatally (25). Serotonin (5-hydroxytryptamine) increases synaptic activity of olfactory bulb glomeruli, acting through serotonin receptors on tufted cells and depolarizing some mitral neurons (36). Myelination in the olfactory bulb and tract have not even been initiated at term and occur in the first few postnatal months (190). In addition to neuronal differentiation, migration, and maturation, a diversity of glial cells with different morphologies develop during fetal life and are not fully developed until term (44). In elderly normal humans and mice, there is a natural regressive change with progressively less glial diversity in the olfactory bulb (107).

Despite neuroanatomical and neurophysiological immaturity, the olfactory system is functional to perceive and react to odors not only in the neonate, but also in the fetus in utero after about 28 to 30 weeks’ gestation, as shown in prenatal clinical and real-time ultrasonographic studies (196). Molecules of foods with strong odors that the mother ingests, such as garlic, onion, curries, and spices, are transported trans-placentally and dissolved in the amniotic fluid, which circulates through the nasal passages with fetal respiratory movements. The fetus reacts differentially to different odors, with graded changes in heart rate and movements (122; 84; 140; 201; 200). Preterm and term postnatal infants show a gradient of olfactory responses (128; 187; 136). Whether fetal and neonatal exposures to strong food odors later influence preferences or aversions to certain foods remains speculative. Human olfactory perception is not just an analytical process of molecular detection alone but is influenced by experience and other interpersonal characteristics (28). Diet also may play a role in olfactory dysfunction (213). Nevertheless, odor dynamics also are encoded in the olfactory system and influence related behavior (03).

The olfactory tract is much more than a simple axonal fasciculus to conduct mitral cell axons from the olfactory bulb to the anterior olfactory nucleus, amygdala, hypothalamus, hippocampus, and entorhinal cortex (part of the parahippocampal gyrus). The tract contains as much grey as white matter and includes extensions of the granular cell core of the olfactory bulb at one end and nodules of the anterior olfactory nucleus at the other, in addition to the soma and long processes of progenitor cells (190). The distal part of mitral cell axons as they emerge from the olfactory tract in humans divide into four fascicles, called the medial, lateral, intermediate, and superior olfactory striae, each with a different target structure (54). These striae also can be demonstrated in the living patient by diffusion tensor imaging (66). The olfactory is the only special sensory system to not project to the thalamus for intermediate relay to the neocortex because it contains its own intrinsic thalamic equivalent within the olfactory bulb and tract: (1) the core of GABAergic granular neurons which lack axons and form intrinsic dendrodendritic synapses; (2) periglomerular interneurons that coexpress GABA and dopamine; and (3) the anterior olfactory nucleus which is a series of nodules (190; 193; 194). In the revised scheme of human neural tube segmentation, both the thalamus and olfactory bulb are derived from prosomere 2, hence, embryology also supports the concept of an independent olfactory thalamus (168; 38).

A unique feature of the olfactory nerve is that it appears to be the only sensory cranial nerve that lacks a peripheral ganglion. However, the synaptic glomeruli at the ventral surface of the olfactory bulb serve the same function as a ganglion, but with primitive evolutionary and ontogenetic structure because of a paucity of neural crest in the region of the developing olfactory placode, which has misled some clinicians into questioning whether the olfactory is a “true” cranial nerve (195). Compartmentalization of the olfactory bulb glomeruli occurs in the postnatal period in rats (98; 102). A segmental architecture also occurs in the piriform cortex (entorhinal area), which puts in order afferent fibers from the anterior olfactory nucleus and directs tertiary efferent olfactory axonal projections (203; 162).

The olfactory nerve is also unique in having its axons rather than being grouped as a compact nerve because the axons must pass individually or in small groups through the multiple fenestrations of the bony cribriform plate; however, after entering the cranial cavity they group as a single compact fascicle that forms the first layer of the olfactory bulb.

The olfactory epithelium also follows a progressive development in fetal life and is not yet fully mature at birth (157; 169; 147; 103). The olfactory epithelium expands greatly in area, enabling a larger number of primary olfactory neurons, with the development of the turbinate bones in the nasal cavity at 8 to 12 weeks gestation; the olfactory epithelium covers most of the superior and part of the middle turbinates, but not the inferior (202). There is continuous turnover of neurons in the olfactory epithelium throughout life with physiological apoptosis and regeneration by progenitor cells (131). Olfactory thresholds are determined in part by specific receptors of primary olfactory neurons in the nasal mucosa (164).

Neuroanatomic studies have shown that the GnRH secreting neurons of the hypothalamus originate in the olfactory placode and migrate across the olfactory bulb to ultimately reach their final location in the hypothalamus. Defective migration of neuroendocrine GnRH cells may contribute to human arrinencephalic malformations (221). In Kallmann syndrome, these cells and nerves apparently develop normally but then fail to migrate, suggesting that the gene encodes a factor needed for the migration of GnRH cells. The beta-secretase enzyme BACE1, deficient in Alzheimer disease, is essential for axonal guidance of olfactory sensory neurons and normal formation of synaptic glomeruli in the olfactory bulb (173). The axonal guidance protein Draxin, related to DSCAM (Down syndrome cell adhesion molecule), also is important in olfactory bulb development as an inhibitory factor that binds multiple netrin receptors; in Draxin knockout mice, neurite outgrowths from olfactory bulb explants are less inhibited than in wild-type mice (07). The transcription factor Tbr2 is expressed in glutamatergic excitatory neurons; mice with deficiency of this factor in mitral and tufted neurons show disruption of the excitatory-inhibitory balance of neural circuitry (142); though it has not been demonstrated in humans, theoretically it could be a genetic cause of impaired olfaction.

Mutations in Kallmann syndrome 1 (KAL 1) gene on the xp22.3 site result in the X-linked form of the syndrome; mutations on the KAL 2 gene (fibroblast growth receptor 1) underlie one autosomal dominant form (62; 199). Abnormalities of both these genes are expressed in a variety of embryonic tissues, thus, leading to the different clinical expressions of the syndrome in addition to the core feature of anosmia. Mutant mice with Pax6 deficiency exhibit decreased volume of the olfactory bulb (but also of the total brain) and altered lamination of the piriform cortex (33). Fibroblast growth factor receptor 1 mutations alone may produce the phenotype of Kallmann syndrome in children (249). The prokineticin receptor PKR2 has been identified in mice with olfactory bulb agenesis and anomalies of the reproductive system (139; 167), and a missense mutation is present in some human cases of Kallmann syndrome, transmitted as an autosomal dominant trait (63; 186). The FGFR1 gene is mutated in some cases of Kallmann syndrome (150).

The detection of Kallmann syndrome mRNA in other tissues including brain, muscle, and kidney suggests that its absence may account for the non-neuronal symptoms found as part of the syndrome (125). Even within the brain, the gene may be important for the development of structures unrelated to the olfactory system or hypothalamus, such as the inhibitory fibers of the corpus callosum that suppress synkinetic or mirror movements (51). Dental agenesis occurs in some individuals with FGFR1 mutations (21).

Not all cases of olfactory bulb agenesis are Kallmann syndrome. This minor malformation also can occur as an isolated defect in brain development and, with the exception of anosmia, is not associated with other brain malformations or with clinical neurologic deficits, including epilepsy, developmental delay, mental retardation, or cognitive and memory problems (60; 39). The diagnosis is confirmed by clinical demonstration of anosmia (testing of cranial nerve 1) and by MRI with special attention to the olfactory bulbs. Neuropathologically, it can be demonstrated in fetuses, infants, and children not only by absence of the olfactory bulbs and tracts but also by absence of the olfactory grooves at the base of the frontal lobes where these structures normally lie. Olfactory agenesis is accompanied microscopically by hypoplasia, neuronal deficiency, and disorganized laminar architecture of the entorhinal cortex (parahippocampal gyrus), a principal projection site of olfactory tract axons.

Agenesis of olfactory bulbs in 22-week fetus

Ventral view of the base of the frontal and temporal lobes of a 22-week female fetus showing agenesis of the olfactory bulbs, without even a remnant of the olfactory tracts and absence of the longitudinal olfactory grooves on eith...

Some other genetic mutations in which agenesis of the olfactory bulbs are an associated anomaly are Prader-Willi syndrome (101), Waardenburg syndrome associated with SOX10 mutation (67), and Bardet-Biedl syndrome (216). Mendelian transmission traits that also involve epigenetic mechanisms occur in several chromosomopathies: Rubinstein-Taybi, CHARGE, Kleefstra, and Weaver syndromes (10).

Olfactory receptor neurons project from the sensory epithelium to stereotypical targets within the olfactory bulb. Studies have demonstrated, unexpectedly, that there is a somatotopic spatial map – with a precision similar to that found in the visual and auditory systems – that enables the distinction of thousands of odors (121). This topographic olfactory-epithelium-to-olfactory-bulb map is particularly of interest in terms of plasticity, because there is a constant turnover throughout life of olfactory sensory neurons, both under normal conditions and after injury (16; 55). A protein associated with the fragile-X mental retardation syndrome is one of several that regulate neuronal differentiation in the adult olfactory bulb (205). Nonapoptotic caspase signaling is required for proper neural network formations during olfactory development (151). The HES family of genes regulates sequential stages of neurogenesis in the olfactory epithelium (40). In the ontogenesis of the olfactory bulbs, there is an intimate glial-neuronal interaction in the formation of the synaptic glomeruli (20). Olfactory nerve ensheathing cells differ from the usual Schwann cells of the peripheral nervous system in their interactions with olfactory bulb astrocytes (113).

Entorhinal cortex exerts an inhibitory effect on olfactory input to the basolateral amygdaloid nucleus and piriform cortex (144). Olfactory integration at the cortical level is impaired if the hypothalamic neuropeptide melanin-concentrating hormone is abolished in mice (04). Anosmia and similar cortical olfactory integration occur in a murine model of human fetal alcohol syndrome (239) and after fetal exposure to the neurotoxic effects of lipopolysaccharide in rats (105). Fetal alcohol syndrome also can cause abnormal development of the olfactory bulb with impaired odor discrimination after mice reach maturity (09); the syndrome can also cause defective early olfactory preference learning in early postnatal mice and rats that later can affect behavior (104).

Another gene recognized in mice, in which poor expression impairs development of the eye and olfactory bulb, is an isoform of Pax6 lacking the paired domain (99). A neuroligin-3-deficient murine model of olfactory hypoplasia may be a model of a monogenic heritable form of autism (172).

Olfactory bulb agenesis may be associated with agenesis of the corpus callosum and may in part be a disorder of axonal guidance (68). Callosal agenesis and alteration of the anterior commissure, through which some olfactory projections normally pass, may be induced in fetal mice by laser destruction of the primordia of the olfactory bulbs, suggesting that the olfactory bulbs may be one of the induction factors for the forebrain commissures (148). Agenesis of both the olfactory bulbs and corpus callosum similarly is seen in cerebral cortical lissencephaly due to mutation in the TUBA1A gene and is also sometimes associated with ocular anomalies (152; 146) and rhombencephalosynapsis of the cerebellum, with or without holoprosencephaly (92). Agenesis of both the corpus callosum and olfactory bulbs also is reported in an infant with congenital maxillomandibular fusion and duplication of the craniofacial midline (137). Other genetic syndromes with agenesis of hypoplasia of both the corpus callosum and olfactory bulbs are the acrocallosal and Grieg cephalopolysyndactyly syndromes, which involve KIF7 and GLI3 gene mutations in their relation to SHH (214).

By contrast with anosmia, infants with fetal alcohol spectrum disorder may exhibit a postnatal enhancing effect on behavioral and neural responses to alcohol, including augmented olfactory perception, which is ameliorated by administration of naltrexone (245). Impaired olfaction is common secondary to the cytotoxic effects on both the olfactory nasal epithelium and the olfactory bulbs of chemotherapeutic agents used in the treatment of cancer, with or without anatomical infiltration by neoplastic cells. Olfaction may be altered clinically, with or without olfactory bulb hypoplasia in congenital infections such as cytomegalovirus disease in humans and murine models (116). Haploinsufficiency of a causative gene of autism, Tbr1, results in impairment of olfactory discrimination in mice (88).

Unilateral olfactory bulb agenesis is much rarer than bilateral agenesis but may occur with ipsilateral sinonasal aplasia and orbital cyst and can be diagnosed by high-resolution CT and MRI (232). Asymmetrical olfactory bulb hypoplasia also may occur, at times associated with ipsilateral optic nerve hypoplasia.

Focal hypoplasia of the olfactory bulb and tract

The principal well-documented olfactory dysplasias are the presence of a deep longitudinal sulcus on the inferior surface with synaptic glomeruli lining the neural tissue on either side of the sulcus, as in hemimegalencephaly; hamartomatous megalocytic and dysplastic neurons in tuberous sclerosis (56) and in hemimegalencephaly (177; 190); fusion of the two olfactory bulbs; and delayed maturation of expression of neuronal proteins and synapse formation (190). Enlarged olfactory bulbs in hemimegalencephaly may be demonstrated by CT and MRI during life (01) and neuropathologically postmortem (177; 190). Less is known about dysplasias of the olfactory bulb than about other parts of the brain in part because even in autopsies of fetal and infant brains with major malformations, the neuropathological examination of the olfactory bulb is usually limited to a gross description of its presence or absence, and samples for histological and immunocytochemical examination rarely are taken. In tuberous sclerosis complex, another mTOR disorder as a somatic mutation associated with germline mutations of TSC1 or TSC2 genes, olfactory bulb agenesis or hypoplasia is frequent, as demonstrated by MRI (135).

Together with the polymorphic zone in the hilus of the dentate gyrus of the hippocampus, the olfactory bulb is one of the two brain regions in which neuronal regeneration and stem cell utilization is greatest in rodents, nonhuman primates, and humans, after traumatic or hypoxic/ischemic injury (55; 109). This plasticity is important not only for the recovery of olfactory sense, but the olfactory bulb can be an important source of stem cells for transplantation into other parts of the brain and spinal cord after injury. Not only the olfactory bulb, but also the olfactory mucosa is a site of resident stem cells in the mature rodent and human; diseases that affect this sensory mucosa may deplete the population of progenitor cells so that anosmia may result (79). Chemotherapy may abolish or suppress progenitor cells of the olfactory bulb, including in patients in whom the bulb is infiltrated by abnormal cells, as in neurocutaneous melanocytosis (190) or by neoplastic cells in the surrounding leptomeninges.

Olfactory auras in focal epilepsy are well documented after the initial observations by Hughlings Jackson in 1871 (93). In a retrospective study of 806 adult patients with focal epilepsy and an additional 169 with primary generalized epilepsy, the overall prevalence of olfactory auras was 3.9%, and for just those with focal epilepsy, 4.22%, especially if the epileptogenic EEG focus was in the mesial temporal lobe (220). In 1954, Penfield and Jasper, in their classical textbook, noted that olfactory auras could be produced by electrical stimulation of the olfactory bulb during epilepsy surgery (158). These observations and subsequent studies of the development and synaptic organization of the olfactory bulb led to a hypothesis that the olfactory bulb was actually the initial generator of olfactory auras in temporal lobe epilepsy (190) and that the amygdala, insula, or entorhinal cortex mediated the perception and brought it to conscious awareness (193). Impaired olfactory discrimination occurs in adult cases of focal epilepsy, usually arising in epileptogenic foci in mesial temporal lobe structures, including focal cortical focal dysplasias of piriform cortex (at the junction of the temporal and frontal lobes) and hippocampal sclerosis (69). A variety of electrophysiological responses to different odors in adult humans are recorded from the amygdala, hence this structure might be another source of olfactory auras (89). Not only auras but impaired olfactory perception and acuity are experienced by patients with either left or right temporal lobe epilepsy, unrelated to duration and baseline frequency of seizures or type of medication used (59). Olfactory hallucinations were reported in an adult with an anxiety disorder but not epilepsy (94). Basal forebrain electrophysiological recordings from regions regulating olfactory processing demonstrate differences between patients with autistic spectrum disorder and controls (233).

Olfactory hallucinations also are described in patients with migraine, but unlike visual and other sensory auras, they are not presently part of the International Classification of Headache Disorders (47; 08).

In adult neurodegenerative diseases, particularly those associated with alpha-synuclein expression, loss of olfactory sense is a frequent symptom and is diagnostically useful (163). In a murine model of Alzheimer disease, α-synuclean appears early in the olfactory bulbs and extends from there into the cerebrum (229). Certain neurons in the olfactory bulb (external plexiform, granular and glomerular layers) and tract express secretagogin, a cytosolic calcium-binding protein coexpressed with calretinin and beta-III-tubulin, and fail to differentiate terminally for synaptic contact or may lose their connectivity in Alzheimer disease, which may be part of the pathogenesis in neurodegenerative diseases (17). Olfactory discrimination and perception often are diminished or lost in normal aging due to atrophy of both the olfactory mucosa with loss of primary olfactory neurons and also the olfactory bulb (18), and also the loss of diversity of glial cell types (107).

Murine models are available of various human genetic mutations or deletions in which olfaction is impaired and the olfactory bulb is hypoplastic or anatomically altered: fragile-X syndrome (112), Down syndrome (53), KBG syndrome (ankyrin repeat domain 11) (80) and Shank3 deficiency associated with reduction in GABA receptors and in humans with autistic spectrum disorder (141). Olfactory bulb disorders also are associated with facial dysmorphism in chick and pig embryos after embryonic exposure to teratogens (234).

Differential diagnosis

Rare cases of isolated hypoplasia of the olfactory bulbs may be the result of a local insult to the cribriform plate in early fetal life (124).

In deficiency of GnRH in the male, the testes are normal but remain in the prepubertal state. Absent or delayed puberty should lead to consideration of Kallmann syndrome in either sex as one possible cause, and specific testing for anosmia is confirmatory. Fifty percent of individuals with hypogonadotrophic hypogonadism do not have a positive family history or anosmia; further experience will tell whether these are formes fruste of the syndrome (50). Disorders of the cerebellum or pes cavus occur in 40%, mirror movements in 60% (204), and mental handicap may also be present.

Arrhinencephaly is a constant feature of alobar and semilobar holoprosencephaly, although rudiments of an olfactory bulb may sometimes be recognized histologically near the olfactory trigone region (192). Other midline cerebral malformations, such as septo-optic-pituitary dysplasia, also frequently are accompanied by hypoplasia or aplasia of olfactory structures and the olfactory groove at the base of the frontal lobe (196; 24). Olfactory agenesis is a frequent, but not constant feature of Meckel-Gruber syndrome, which is a complex cerebral malformation that includes encephalocele (06). Dysgenesis, rather than agenesis, of the olfactory bulbs occurs in some genetic syndromes, such as short-rib-polydactyly syndrome, and may be asymmetrical and associated with other cerebral malformations (242). This human syndrome is of interest because there is a murine model of arrhinencephaly and hydrocephalus, also associated with polydactyly (87; 149), and the defect in these mice appears to be downregulation or suppression of the Gli3 gene without alteration of sonic hedgehog (Shh) expression (231; 230). Primary cilia control telencephalic patterning including olfactory bulb formation via Gli3 proteolytic processing (26). The association of polydactyly in both the mouse and human phenotypes suggests that this gene or a related one might also be responsible in humans. A 4-generation family had decreased sense of smell associated with polydactyly and other anomalies (23). The homozygous mouse embryos also develop exencephaly (encephalocele) when exposed to valproic acid (129).

Though impaired olfaction is described in some girls with Rett syndrome, a murine model of Mecp2 genetic mutation exhibited normal mitral cell dendritic development and did not support the hypothesis that this gene plays an important role in olfactory ontogenesis (154).

Olfactory micronodules associated with olfactory impairment may occur in tuberous sclerosis and also in mice with Tsc1 deletions (71).

Bilateral olfactory bulb agenesis was found in seven or eight patients with Waardenburg syndrome, types 2 and 4 associated with SOX10 mutations; they also have impaired hearing and abnormalities of the cochlear nerves and internal auditory canals of the temporal bones (67). SOX10 has the same genetic mutation as in Kallmann syndrome with deafness (160). SOX9 mutations cause campomelic dysplasia and haploinsufficiency with agenesis of the olfactory bulbs (52).

Simple olfactory bulb agenesis without other malformations is rare but known, and might result from a brief single exposure to a teratogen on the 41st day of gestation, or from a limited defect in genetic programming of olfactory bulb development; it also is demonstrated in the brains of some infants with trisomy 13 without other features of holoprosencephaly (188).

Olfactory groove meningioma is the most frequent tumour that could invade the olfactory bulb and cause anosmia, but it would not be a congenital lesion (45). A rarer tumour is olfactory bulb Schwannoma (70). Amongst neurocutaneous syndromes, a dysplasia with neoplastic transformation that infiltrates the olfactory bulbs in early life is neurocutaneous melanocytosis (73). Tumors of the olfactory bulb itself, such as olfactory neuroblastoma, are a rare cause of altered perception or loss of olfactory function (165; 143). Radiotherapy administered to patients with nasopharyngeal neoplasms reduces olfactory bulb volume and diminishes olfactory function (236).

Anatomical anomalies of the nose and face at times are accompanied by olfactory impairment and defects in peripheral olfactory pathways and even the olfactory bulb. Examples are nonsyndromic orofacial clefts (27; 180), deviations of the nasal septum, shallow olfactory fossa and defective cribriform plate (184), and choanal atresia that is part of the CHARGE syndrome (41).

Diagnostic workup

Olfactory reflexes may be tested in the neonate or in infancy using nonirritative aromatic substances. In reality, all molecules that stimulate olfactory receptors also can trigger trigeminal pain receptors in the nasal mucosa, but it is a matter of ratio (64); peppermint is predominantly olfactory, whereas ammonia is predominantly painful. Peppermint elicits sucking or arousal-withdrawal when the child is content, not crying, and not in quiet (deep) sleep. It is a reliable reflex after 32 weeks’ gestation but frequently can be elicited as early as 28 weeks (187). Neonatal olfactory reflexes have been confirmed by other authors (76). This reflex is clinically useful in the assessment of neonates with suspected cerebral malformations, particularly holoprosencephaly because of its association with arrhinencephaly (192).

MRI provides the best objective manner of confirming agenesis or hypoplasia of the olfactory bulbs, even by subjective impression without quantitative volumetry, and they also can assess the olfactory groove for further confirmation (22; 65; 117). The olfactory tract and its striae can be demonstrated by diffusion tensor MRI (66). MRI4 also is useful in children and adults with new onset of olfactory loss of unknown origin (86).

Olfactory bulbs in normal 9-year-old boy (MRI)

Normal coronal T2-weighted MRI of a 9-year-old boy showing well formed olfactory bulbs as white round images on either side of the midline just above the horizontal cribriform plate and the perpendicular (vertical) plate of the et...
Olfactory bulbs 12-year-old boy with hypoplasia (MRI)

Coronal T2-weighted MRI in 2 sections 4 mm apart of a 12-year-old boy with hypoplasia, but not total agenesis, of the olfactory bulbs. The brain was otherwise normal, and he did not have Kallmann syndrome, endocrinopathies, or neu...
Olfactory bulbs in children (comparison MRIs)

(A) Coronal T2-weighted images through olfactory bulbs. The olfactory bulbs (arrows) appear as black dots surrounded by bright CSF. The olfactory sulci (arrowheads) are well seen. (B) Partial magnification of figure A. The crista ...
Focal hypoplasia of the olfactory bulb and tract

Axial T2-weighted MRI of a 7-year-old girl with focal hypoplasia of the left olfactory bulb and tract. She also has left optic nerve hypoplasia (not shown). The right olfactory bulb and the optic nerve are of expected size and app...

In conventional MRI, the olfactory bulbs are best seen in the coronal plane in T2-weighted images at a level at the posterior half of the orbits that includes the turbinate bones, the horizontally oriented cribriform plate and crista galli, and the vertically oriented plate of the ethmoid bones. The olfactory bulbs also can be identified in the axial plane of MRI. The volume of the olfactory bulb and the depth of the olfactory sulcus can be quantitatively measured (178). A shallow olfactory sulcus is sometimes seen in schizophrenia and may indicate an early embryonic disruption (226). The olfactory recess of the rostral ventral part of the frontal horn of the lateral ventricle is prominent in embryonic life until about 26 weeks’ gestation, but MRI may demonstrate persistence of this olfactory ventricle in some cases postnatally as an incidental asymptomatic finding (210).

Olfactory bulbs may be demonstrated reliably by MRI after 30 weeks gestation, and hypoplasia of these structures also documented by late prenatal and early postnatal MRI (19; 196). On postnatal MRI, normal olfactory bulbs are nearly always identifiable on 3 mm coronal spin-echo T2-weighted images (248). The recognition is easy in infants because of their prominent bifrontal subarachnoid fluid spaces. With 3-dimensional high-resolution T2-weighted images, the olfactory bulbs can be identified in both axial and coronal planes, the latter at the level of the posterior orbits (248). The olfactory tract is distinguished from the bulb by a change in calibre, but a clear neuroanatomical landmark is lacking (31). A normal olfactory bulb is usually accompanied by an olfactory sulcus, previously called the olfactory groove on the ventral surface of the gyrus rectus and in which the olfactory bulb and tract lie, and it is also readily identifiable in both axial and coronal T2-weighted images. Absence of the olfactory bulbs can be bilateral or unilateral, both conditions diagnosed with confidence by MRI. Absence of the olfactory bulb nearly always is accompanied by absence of the olfactory sulcus. Congenital arhinia (absence of the external nose, nasal cavities, olfactory epithelia, and olfactory bulbs) is a rare malformation diagnosed prenatally by fetal MRI (120).

Computed tomography of the anterior cranial base in agenesis of the olfactory bulb reveals hypoplasia of the ethmoid bone, through which the axons of the olfactory receptor cells pass to reach the bulb (133).

Endocrine investigations in the prepubertal age group are unsatisfactory, but in adults the assay of subnormal levels of gonadal steroids and gonadotrophins are straightforward. Screening for possible associated renal malformations is indicated. MRI using coronal slices has demonstrated abnormalities of the olfactory system (108; 224; 247), and other work has shown that there is bilateral absence of the olfactory bulbs, tracts, and sulci in approximately two thirds of the cases of Kallmann syndrome, whereas in the remainder they are only present unilaterally or are hypoplastic or rudimentary (75; 171; 246). In the normal human fetus, olfactory sulci can be reliably detected from 30 weeks’ gestation and the olfactory bulbs from 30 to 34 weeks (19). MRI also is useful for assessing the olfactory bulbs in anosmic patients after traumatic head injury (240). Posttraumatic anosmia may in part be due to damage to cerebral centers of olfaction but not just to the olfactory bulbs (179).

Bilateral responses to unilateral magnetic stimulation of the motor cortex have been reported in the syndrome (51). The X-linked form of Kallmann syndrome has been localized to the Xp22.3 site by genetic linkage studies. Contiguous gene syndromes such as associated steroid-sulfatase deficiency with X-linked ichthyosis, in which there are deletions of neighboring portions of the short arm of the X-chromosome, can be identified by DNA analysis (166).

Vascular anomalies also should be considered in the differential diagnosis of olfactory impairment. The olfactory artery is a primitive transitory fetal vessel arising from the proximal anterior cerebral artery that may persist; MR angiography may demonstrate rare aneurysms of that vessel (243; 228) or even arteriovenous fistulae also involving the anterior ethmoidal arteries (225) or mixed pial-dural arteriovenous malformations that involve a primitive olfactory artery (95).

Congenital infections such as cytomegalovirus may cause olfactory bulb hypoplasia and prenatal infarction. Postnatally acquired cytomegalovirus also can result in olfactory atrophy. COVID-19 infection regularly reduced perception of odor and taste in adults (11; 207; 237), and MRI in anosmic patients with COVID-19 discloses olfactory bulb abnormalities, such as altered signal intensity ratios that are not found in COVID patients with preserved sense of smell (42). Nonolfactory additional MRI findings may include subcortical white matter abnormalities and cerebral microhemorrhages (05). In long COVID-19 and afterward, there often are other symptoms such as chronic headache, mental clouding, and memory and cognition deficits (61; 72; 145). Viral entry into and replication within the sustentacular (ensheathing) cells of the olfactory nerve fibres is the likely mechanism of pathogenesis (208). MRI studies may demonstrate atrophy of the olfactory epithelium and bulbs (43; 219), but these findings may be transitory and recover in follow-up imaging (13). Immunological study of patients with long COVID-19 reveal a likely role of endothelial activation and clotting abnormalities and diverse auto-antibody specificities, but the data remain insufficient for mechanistic synthesis (12).

Clinical testing of olfactory perception and discrimination is useful in adults with suspected dementia or mild cognitive impairment because loss of olfactory is an early sign in senility or neurodegenerative diseases (223).

Media

References

01: Abdelhalim AN, Moritani T, Richfield E, Ekholm SE, Westesson PL. Epidermal nevus syndrome: megalencephaly with bihemispheric and cerebellar involvement: imaging and neuropathological correlation. J Comput Assist Tomogr 2003;27(4):534-7. PMID 12886138
02: Abolmaali ND, Hietschold V, Vogl TJ, et al. MR evaluation in patients with isolated anosmia since birth or early childhood. Am J Neuroradiol 2002;23:157-64. PMID 11827889
03: Ackels T, Erskine A, Dasgupta D, et al. Fast odour dynamics are encoded in the olfactory system and guide behaviour. Nature 2021;593(7860):558-63. PMID 33953395
04: Adams AC, Domouzoglou EM, Chee MJ, et al. Ablation of the hypothalamic neuropeptide melanin concentrating hormone is associated with behavioral abnormalities that reflect impaired olfactory integration. Behav Brain Res 2011;224:195-200. PMID 21669232
05: Afsahi AM, Norbash AM, Syed S, et al. Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis. J Neurol 2023;270(11):5131-54. PMID 37535100
06: Ahdab-Barmada M, Claassen D. A distinctive triad of malformations of the central nervous system in the Meckel-Grüber syndrome. J Neuropathol Exp Neurol 1990;49(6):610-20. PMID 2230839
07: Ahmed G, Shinmyo Y, Ohta K, et al. Draxin inhibits axonal outgrowth through the netrin receptor DCC. J Neurosci 2011;31:14018-23. PMID 21957262
08: Ahmed MA, Donaldson S, Akor F, Cahill D, Akilani R. Olfactory hallucinations in childhood primary headaches: case series. Cephalgia 2015;35(3):234-9. PMID 24907166
09: Akers KG, Kushner SA, Leslie AT, et al. Fetal alcohol exposure leads to abnormal olfactory bulb development and impaired odor discrimination in adult mice. Mol Brain 2011;4:29. PMID 21736737
10: Aleo S, Cinnante C, Avignone S, et al. Olfactory malformations in Mendelian disorders of the epigenetic machinery. Front Cell Dev Biol 2020;8:710. PMID 32850830
11: Altin F, Cingi C, Uzun T, Bal C. Olfactory and gustatory abnormalities in COVID-19 cases. Eur Arch Otorhinolaryngol 2020;277(10):2775-81. PMID 32577902
12: Altmann DM, Whettlock EM, Liu S, et al. The immunology of long COVID. Nat Rev Immunol 2023;23(10):618-34. PMID 37433988
13: Ammar A, Distinguin L, Chetrot A, et al. Transient modification of the olfactory bulb on MR follow-up of COVID-19 patients with related olfactory dysfunction. J Neuroradiol 2022;49(4):329-32. PMID 35306004
14: Ashwell KW, Marotte LR, Cheng G. Development of the olfactory system in a wallaby (Macropus eugenii). Brain Behav Evol 2008;71(3):216-30. PMID 18322362
15: Assouline S, Shevell MI, Zatorre RJ, et al. Children who can’t smell the coffee: isolated congenital anosmia. J Child Neurol 1998;13:168-72. PMID 9568760
16: Astic L, Saucier D. Neuronal plasticity and regeneration in the olfactory system of mammals: morphological and functional recovery following olfactory bulb deafferentation. Cell Mol Life Sci 2001;58(4):538-45. PMID 11361089
17: Attems J, Alpar A, Spence L, et al. Clusters of secretagogin-expressing neurons in the aged olfactory tract lack terminal differentiation. Proc Natl Acad Sci USA 2012;109(16):6259-64. PMID 22474393
18: Attems J, Walker L, Jellinger KA. Olfaction and aging: a mini-review. Gerontology 2015;61(6):485-90.** PMID 25968962
19: Azoulay R, Fallet-Bianco C, Garel C, Grabar S, Kalifa G, Adamsbaum C. MRI of the olfactory bulbs and sulci in human fetuses. Pediatr Radiol 2006;36(2):97-107. PMID 16341529
20: Bailey MS, Puche AC, Shipley MT. Development of the olfactory bulb: evidence for glia-neuron interactions in glomerular formation. J Comp Neurol 1999;415(4):423-48. PMID 10570454
21: Bailleul-Forestier I, Gros C, Zenaty D, et al. Dental agenesis in Kallmann syndrome individuals with FGFR1 mutations. Int J Paediatr Dent 2010;20:305-12. PMID 20536592
22: Barkovich AJ. Pediatric Neuroimaging. 4th ed. Lippincott Williams & Wilkins, 2005:404.
23: Belligni EF, Hennekam RC. Familial occurrence of ptosis, nasal speech, prominent ears, hand anomalies and learning problems. Eur J Med Genet 2010;53:192-6. PMID 20362700
24: Benson JC, Nascene D, Truwit C, McKinney AM. Septo-optic dysplasia: assessment of associated findings with special attention to the olfactory sulci and tracts. Clin Neuroradiol 2019;29(3):505-13. PMID 29663010
25: Bergmann M, Schuster T, Grabs D, et al. Synaptophysin and synaptoporin in the developing rat olfactory system. Brain Res Dev Brain Res 1993;74(2):235-44. PMID 8403385
26: Besse L, Neti M, Anselme I, et al. Primary cilia control telencephalic patterning and morphogenesis via Gli3 proteolytic processing. Development 2011;138:2079-88. PMID 21490064
27: Biacabe B, Faulcon P, Amanou L, Bonfils P. Olfactory cleft disease: an analysis of 13 cases. Otolaryngol Head Neck Surg 2004;130(2):202-8. PMID 14990917
28: Bierling AL, Croy I, Hummel T, Cuniberti G, Croy A. Olfactory perception in relation to the physicochemical odor space. Brain Sci 2021;11(5):563. PMID 33925220
29: Billesbelle CB, de March CA, van der Veiden WJC, et al. Structural basis of odorant recognition by a human odorant receptor. Nature 2023;615(7953):742-9. PMID 36922591
30: Blakeslee AF. Unlike reaction of different individuals to fragrance in verbena flowers. Science 1918;48:298-9. PMID 17801704
31: Blitz AM, Macedo LL, Chonka ZD, et al. High-resolution CISS MR imaging with and without contrast for evaluation of the upper cranial nerves: segmental anatomy and selected pathologic conditions of the cisternal through extraforaminal segments. Neuroimag Clin N Am 2014;24(1):17-34. PMID 24210310
32: Bodaleo F, Tapia-Monsalves C, Cea-Del-Rio C, Gonzalez-Billault C, Nunez-Parra A. Structural and functional abnormalities in the olfactory system of fragile X syndrome models. Front Mol Neurosci 2019;12:135. PMID 31191246
33: Boretius S, MIchaelis T, Tammer R, et al. In vivo MRI of altered brain anatomy and fiber connectivity in adult Pax6-deficient mice. Cereb Cortex 2009;19:2838-47. PMID 19329571
34: Bovetti S, Peretto P, Fasolo A, De Marchis S. Spatio-temporal specification of olfactory bulb interneurons. J Mol Histol 2007;38(6):563-9. PMID 17588153
35: Brang D, Ramachandran VS. Olfactory bulb dysgenesis, mirror neuron system dysfunction, and autonomic dysregulation ass the neural basis for autism. Med Hypotheses 2010;74:919-21. PMID 20149551
36: Brill J, Shao Z, Puche AC, Wachowiak M, Shipley MT. Serotonin increases synaptic activity in olfactory bulb glomeruli. J Neurophysiol 2016;115(3):1208-19. PMID 26655822
37: Carboni AA, Cullen KJ, Lavelle WG. The effects of zinc on the olfactory neuroepithelium and olfactory bulbs of the Sprague-Dawley rat after oral administration of zinc-gluconate trihydrate. Am J Rhinol 2006;20(3):262-8. PMID 16871926
38: Carstens MH, Sarnat HB. Neuromeres: The timing and sequence of their appearance and their relationship to brain development. In: Carstens MH, editor. Developmental principles of head and neck anatomy: The neuromeric basis of craniofacial structure. Berlin, NY: Springer-Verlag, 2018.
39: Carswell AJ, Whinney D, Hollings N, Flanagan P. Isolated olfactory nerve agenesis. Br J Hosp Med 2008;69:474. PMID 18783101
40: Cau E, Gradwohl G, Casarosa S, Kageyama R, Guillemot F. Hes genes regulate sequential stages of neurogenesis in the olfactory epithelium. Development 2000;127(11):2323-32. PMID 10804175
41: Chalouhi C, Faulcon P, Le Bihan C, et al. Olfactory evaluation in children: application to the CHARGE syndrome. Pediatrics 2005;116(1):e81-8. PMID 15958661
42: Chetrit A, Lechien JR, Ammar A, et al. Magnetic resonance imaging of COVID-19 anosmic patients reveals abnormalities of the olfactory bulb: preliminary prospective study. J Infect 2020;81(5):816-46. PMID 32739489
43: Chiu A, Fischbein N, Wintermark M, Zaharchuk G, Yun PT, Zeineh M. COVID-19-induced anosmia associated with olfactory bulb atrophy. Neuroradiology 2021;63(1):147-8. PMID 32930820
44: Chiu K, Greer CA. Immunocytochemical analysis of astrocyte development in the olfactory bulb. Brain Res Dev Brain Res 1996;95(1):28-37. PMID 8873973
45: Ciurea AV, Iencean SM, Rizea RE, Brehar FM. Olfactory groove meningiomas; a retrospective study on 59 surgical cases. Neurosurg Rev 2012;35:195-202. PMID 21960302
46: Clepce M, Reich K, Gossler A, et al. Olfactory abnormalities in anxiety disorders. Neurosci Lett 2012;511:43-6. PMID 22306090
47: Coleman ER, Grosberg BM, Robbins MS. Olfactory hallucinations in primary headache disorders: case series and literature review. Cephalgia 2011;31(14):1477-89. PMID 21945891
48: Cortez AB, Galindo A, Arensman FW, Van Dop C. Congenital heart disease associated with sporadic Kallmann syndrome. Am J Med Genet 1993;46:551-4. PMID 8322819
49: Costa I, Rodrigues B, Días L Sr. Congenital agenesis of the olfactory bulbs: what to suspect? Cureus 2021;13(1):e12659. PMID 33585143
50: Crowley WF, Jameson JL. Clinical counterpoint: gonadotrophin releasing hormone deficiency: perspectives from clinical investigation. Endocr Rev 1992;13:635-40. PMID 1459047
51: Danek A, Heye B, Schroedter R. Cortically evoked motor responses in patients with Xp22.3 linked Kallmann's syndrome and in female gene carriers. Ann Neurol 1992;31:299-304. PMID 1637137
52: Debuf MJ, Benoit V, Cassart M, et al. Agenesis of olfactory bulbs: a forgotten diagnostic indicator of acampomelic campomelic dysplasia. Clin Case Rep 2019;7(7):1352-4. PMID 31360485
53: de Campos-Gomes F, Faria Santos IB, Stephani CM, et al. Vitamin D3 supplementation may attenuate morphological and molecular abnormalities of the olfactory bulb in a mouse model of Down syndrome. Tissue Cell 2022;78:101898. PMID 36049371
54: de Cannière G. The olfactory striae: an historical perspective on an inconsistent anatomy. J Anat 2023. In press.
55: de Chevigny A, Lledo PM. [Olfactory bulb neurogenesis and its neurological impact]. Med Sci (Paris) 2006;22(6-7):607-13. PMID 16828036
56: de León GA, Zaeri N, Foley CM. Olfactory hamartomas in tuberous sclerosis. J Neurol Sci 1988;87(2-3):187-94. PMID 3210031
57: Della Valle E, Vezzani S, Rochira V, et al. Prevalence of olfactory and other developmental anomalies in patients with central hypogonadotropic hypogonadism. Front Endocrinol (Lausanne) 2013;4:70. PMID 23760293
58: de Morsier G. Median craniocephalic dysraphias and olfactogenital dysplasia. World Neurol 1962;3:485-504. PMID 13884418
59: Desai M, Agadi JB, Karthik N, Praveenkumar S, Netto AB. Olfactory abnormalities in temporal lobe epilepsy. J Clin Neurosci 2015;22(10):1614-8. PMID 26149406
60: Di Rienzo L, Artuso A, Colosimo C. Isolated congenital agenesis of the olfactory bulbs and traces in a child without Kallmann syndrome. Ann Otol Rhinol Laryngol 2002;111:657-60. PMID 12126024
61: Di Stadio A, Brenner MJ, De Luca P, et al. Olfactory dysfunction, headache, and mental clouding in adults with long-COVID-19: What is the link between cognition and olfaction? A cross-sectional study. Brain Sci 2022;12(2):154-65. PMID 35203918
62: Dode C, Hardelin JP. Kallmann syndrome: fibroblast growth factor signaling insufficiency. J Mol Med 2004:82(11):725-34. PMID 15365636
63: Dode C, Teixeira L, Levilliers J, et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2006;2(10):e175. PMID 17054399
64: Doty RL, Brugger WE, Jurs PC, Orndorff MA, Snyder PJ, Lowry LD. Intranasal trigeminal stimulation from odorous volatiles: psychometric responses from anosmic and normal humans. Physiol Behav 1978;20(2):175-85. PMID 662939
65: Duprez TP, Rombaux P. Imaging the olfactory tract (cranial nerve #1). Eur J Radiol 2010;74:288-98. PMID 20303227
66: Echarvarría-Cooper SL, Zhou G, Zelano C, Pestilli F, Parrish TB, Kahnt T. Mapping the microstructure and striae of the human olfactory tract with diffusion MRI. J Neurosci 2022;42(1):58-68. PMID 34759031
67: Elmaleh-Berges M, Baumann C, Noel-Petroff N, et al. Spectrum of temporal bone abnormalies in patients with Waardenburg syndrome and SOX10 mutations. Am J Neuroradiol 2013;34(6):1257-63. PMID 23237859
68: Engle EC. Human genetic disorders of axon guidance. Cold Spring Harb Perspect Biol 2010;2:a001784. PMID 20300212
69: Espinosa-Jovel C, Toledano R, Jiménez-Huete A, et al. Olfactory function in focal epilepsies: understanding mesial temporal lobe epilepsy beyond the hippocampus. Epilepsia Open 2019;00:1-6.
70: Fabbri VP, Papa V, Agati R, et al. Olfactory nerve schwannoma: how anatomy can help to solve an intriguing scientific puzzle. Int J Environ Res Public Health 2022;46(5):490-6. PMID 35913116
71: Feliciano DM, Quon JL, Su T, et al. Postnatal neurogenesis generates heterotopias, olfactory micronodules and cortical infiltration following single-cell Tsc1 deletion. Hum Mol Genet 2012;21:799-810. PMID 22068588
72: Fiorentino J, Payne M, Cancian E, et al. Correlations between persistent olfactory and semantic memory disorders after SARS-CoV-2 infection. Brain Sci 2022;12(6):714. PMID 35741601
73: Flores-Sarnat L. Neurocutaneous melanocytosis. In: Dulac O, Lassonde M, Sarnat HB, editors. Handbook of Clinical Neurology, Vol. 111. New York: Elsevier, 2013:369-88.
74: Friede RL. Development neuropathology. 2nd ed. New York: Springer Verlag, 1989:309-14.
75: Fuerxer F, Carlier R, Iffenecker C, Schaison G, Doyon D. [Magnetic resonance imaging of the olfactory pathways in Kallmann de Morsier syndrome]. J Neuroradiol (Paris) 1996;23(4):223-30 (in French). PMID 9157201
76: Gauthaman G, Jayachandran L, Prabhakar K. Olfactory reflexes in newborn infants. Ind J Pediatr 1984;51:397-9. PMID 6526447
77: Gibbons B. The intimate sense of smell. National Geographic 1986;170:324-60.
78: Gilbert AN, Wysocki CJ. Results of the smell survey. National Geographic 1987;172:514-25.
79: Girard SD, Devéze A, Nivet E, Gepner B, Roman FS, Féron F. Isolating nasal olfactory stem cells from rodents or humans. J Vis Exp 2011 Aug 22;(54). PMID 21876529
80: Goodkey K, Wischmeijer A, Perrin L, et al. Olfactory bulb abnormalities in KBG syndrome mouse model and patients. BMC Med 2024;22(1):158. PMID 38616269
81: Guo L, Cheng J, Lien S, et al. Structural basis of amine odorant perception by a mammal olfactory receptor. Nature 2023;618(7963):193-200. PMID 37225986
82: Henkin RI, Abdlmeguid M, Knöppel AB. Initiation of smell function in patients with congenital hyposmia. Am J Otolaryngol 2016;37(3):175-81. PMID 27178503
83: Henkin RI, Levy LM. Functional MRI of congenital hyposmia. Brain activation to odors and imagination of odors and tastes. J Comput Assist Tomogr 2002;26:39-61. PMID 11801904
84: Hepper P. Human fetal olfactory learning. Int J Prenatal Perinatal Psychol 1995;2:147.
85: Hermanussen M, Sippell WG. Heterogeneity of Kallman's syndrome. Clin Genet 1985;28:106-11. PMID 4042391
86: Hoekman PK, Houlton JJ, Seiden AM. The utility of magnetic resonance imaging in the diagnostic evaluation of idiopathic olfactory loss. Laryngoscope 2014;124(2):365-8. PMID 23775878
87: Hongo T, Hakuba A, Shiota K, Naruse I. Suckling dysfunction caused by defects in the olfactory system in genetic arhinencephaly mice. Biol Neonate 2000;78(4):293-9. PMID 11093009
88: Huang TN, Yen TL, Qiu LR, Chuang HC, Lerch JP, Hsueh YP. Haploinsufficiency of autism causative gene Tbr1 impairs olfactory discrimination and neonatal activation of the olfactory system in mice. Mol Autism 2019;10:5. PMID 30792833
89: Hughes JR, Andy O. The human amygdala. I. Electrophysiological responses to odorants. Electroenceph Clin Neurophysiol 1979;46:428-43. PMID 85539
90: Humphrey T. The development of the olfactory and the accessory olfactory formations in human embryos and fetuses. J Comp Neurol 1940;73:431-68.
91: Huxley TH. On the anatomy and affinities of the family of the Medusae. Phil Trans Roy Soc 1849;139:413-34.
92: Ishak GE, Dempsey JC, Shaw DW, et al. Rhombencephalosynapsis: a hindbrain malformation associated with incomplete separation of midbrain and forebrain, hydrocephalus and a broad spectrum of severity. Brain 2012;135(Pt 5):1370-86. PMID 22451504
93: Jackson JH. Subjective sensations of smell with epileptiform attacks. Lancet 1871;1:376-7.
94: Jiang X, Yuan Y, Li Z, Ou Y, Li Z. First-episode olfactory hallucination in a patient with anxiety disorder: a case report. Front Psychiatry 2022;13:990341. PMID 36203838
95: Jimbo H, Ikeda Y, Izawa H, et al. Mixed pial-dural arteriovenous malformation in anterior cranial fossa: two case reports. Neurol Med Chir (Tokyo) 2010;50:470-5. PMID 20587971
96: Kallmann F, Schoenfeld WA, Berrera SE. The genetic aspects of primary eunuchoidism. Am J Ment Defic 1944;48:203-35.
97: Kapici OB, Kapici Y, Tekin A. Reduced olfactory bulb volume and olfactory sulcus depth in obsessive compulsive disorder. Psychiatry Res Neuroimaging 2023;332:111644. PMID 37087810
98: Kasowski HJ, Kim H, Greer CA. Compartmental organization of the olfactory bulb glomerulus. J Comp Neurol 1999;407(2):261-74. PMID 10213094
99: Kim J, Lauderdale JD. Analysis of Pax6 expression using a BAC transgene reveals the presence of a paired-less form of Pax6 in the eye and olfactory bulb. Devel Biol 2006;292(2):486-505. PMID 16464444
100: Kharlamova AS, Barabanov VM, Savel’ev SV. Development of the olfactory bulbs in human fetuses (an immunohistochemical study). Neurosci Behav Physiol 2010;40(2):131-5. PMID 20033301
101: Khor EC, Fanshawe B, Qi Y, et al. Prader-Willi critical region, a non-translated, imprinted central regulator of bone mass: possible role in skeletal abnormalities in Prader-Willi syndrome. PLoS One 2016;11(1):e0148155. PMID 26824232
102: Kim H, Greer CA. The emergence of compartmental organization in olfactory bulb glomeruli during postnatal development. J Comp Neurol 2000;422(2):297-311. PMID 10842233
103: Kimura M, Umehara T, Udagawa J, Kawauchi H, Otani H. Development of olfactory epithelium in the human fetus: scanning electron microscopic observations. Congenit Anom (Kyoto) 2009;49(3):102-7. PMID 20002901
104: Kirstein CL, Philpot RM, Dark T. Fetal alcohol syndrome early olfactory learning as a model system to study neurobehavioral deficits. Int J Neurosci 1997;89:119-32. PMID 9134450
105: Kirsten TB, Chávez GP, Taricano M, et al. Prenatal LPS exposure reduces olfactory perception in neonatal and adult rats. Physiol Behav 2011;104:417-22. PMID 21570993
106: Kishi K, Peng JY, Kakuta S, et al. Migration of bipolar subependymal cells precursors of granule cells of the rat olfactory bulb with reference to the arrangement of the radial glial fibers. Arch Histol Cytol 1990;53(2):219-26. PMID 2372444
107: Klein M, Lohr C, Droste D. Age-dependent heterogeneity of murine olfactory bulb astrocytes. Aging Neurosci 2020;12:172. PMID 32581775
108: Knorr JR, Ragland RL, Brown RS, Gelber N. Kallmann syndrome: MR findings. Am J Neuroradiol 1993;14:845-51. PMID 8352155
109: Koketsu D, Furuichi Y, Maeda M, Matsuoka N, Miyamoto Y, Hisatsune T. Increased number of new neurons in the olfactory bulb and hippocampus of adult non-human primates alter focal ischemia. Exp Neurol 2006;199(1):92-102. PMID 16712840
110: Kokoreva KD, Chugunov IS, Valdimirova VP, Ivannikova TE, Bogdanov VP, Bezlepkina OB. [Olfactory function and olfactory bulbs in patients with Kallmann syndrome.] Probl Endokrinol (Moscow) 2023;69(2):67-74. PMID 37448273
111: Kousta E, White DM, Piazzi A, et al. Successful induction ovulation and completed pregnancy using recombinant human luteinising hormone and follicle stimulating hormone in a woman with Kallmann syndrome. Hum Reprod 1996;11:70-1. PMID 8671160
112: Kuruppath P, Xue L, Pouille F, et al. Hyperexcitability in the olfactory bulb and impaired fine odor discrimination in the Fmr1 KO mouse model of fragile-X syndrome. bioRxiv 2023;43(48):8243-58. PMID 37788940
113: Lakatos A, Franklin RJ, Barnett SC. Olfactory ensheathing cells and Schwann cells differ in their in vitro interactions with astrocytes. Glia 2000;32(3):214-25. PMID 11102963
114: Laska M, Distel H, Hudson R. Trigeminal perception of odorant quality in congenitally anosmic subjects. Chem Senses 1997;22:447-56. PMID 9279467
115: Layman WS, McEwen DP, Beyer LA, et al. Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome. Hum Mol Genet 2009;18:1909-23. PMID 19279158
116: Lazarini F, Katsimpardi L, Levivien S, et al. Congenital cytomegalovirus infections alters olfaction before hearing deterioration in mice. J Neurosci 2018;38(49):10424-37. PMID 30341181
117: Levy LM, Degnan AJ, Sethi I, Henkin RI. Anatomic olfactory structural abnormalities in congenital small loss: magnetic resonance imaging evaluation of olfactory bulb, groove, sulcal, and hippocampal morphology. J Comput Assist Tomogr 2013;37(5):650-7. PMID 24045236
118: Levy LM, Degnan AJ, Sharma S, Kelahan L, Henkin RI. Morphological changes in olfactory bulbs and grooves: initial report of supernumerary olfactory bulbs. J Comput Assist Tomogr 2012;36(4):404-9. PMID 22805668
119: Lewkowitz-Shpuntoff HM, Hughes VA, Plummer L, et al. Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implicaations. J Clin Endocrinol Metab 2012;97: E136-44. PMID 22072740
120: Li X, Zhang L, Wang F. Prenatal diagnosis of total arhinia by MRI. Jpn J Radiol 2015;33(10):672-4. PMID 26311082
121: Lin DM, Ngai J. Development of the vertebrate main olfactory system. Curr Opin Neurobiol 1999;9(1):74-8. PMID 10072373
122: Lipsitt LP, Engen T, Kaye H. Developmental changes in the olfactory threshold of the neonate. Child Dev 1963;34:371-6.
123: Lois C, García-Verdugo JM, Alvarez-Buylla A. Chain migration of neuronal precursors. Science 1996;271(5251):978-81. PMID 8584933
124: Louis DN, Arriagada PV, Hyman BT, Hedley-Whyte ET. Olfactory dysgenesis or hypoplasia: a variant in the arrhinencephaly spectrum. Neurology 1992;42:179-82. PMID 1734299
125: Lutz B, Rugarli ET, Eichele G, Ballabio A. X-linked Kallmann syndrome. A neuronal targeting defect in the olfactory system. FEBS Lett 1993;325:128-34. PMID 8513884
126: Lyckholm L, Heddinger SP, Parker G, et al. A randomized, placebo-controlled trial of oral zinc for chemotherapy’related taste and smell disorders. J Pain Palliat Care Pharmacother 2012;26:111-4. PMID 22764846
127: Lygonis CS. Familiar absence of sensation. Hereditas 1968;60:413-6.
128: Macfarlane A. Olfaction in the development of social preferences in the human neonate. Ciba Found Symp 1975;33:103-17. PMID 1045976
129: Maekawa M, Ohta K, Katagiri R, Ueta E, Naruse I. Exencephaly induction by valproic acid in the genetic polydactyly/arhinencephaly mouse, Pdn/Pdn. Congenit Anom (Kyoto) 2005;45(4):132-6. PMID 16359493
130: Maestre de San Juan A. Teratología: falta total de los nervios olfactorios con anosmia en un individuo en quien exista una atrofia congénita de los testículos y miembro viril. Bick DP, Ballabio A, trans. Am J Neuroradiol 1993;14:852-4.
131: Magrassi L, Graziadei PP. Cell death in the olfactory epithelium. Anat Embryol (Berl) 1995;192(1):77-87. PMID 7486003
132: Mainland RC. Absence of olfactory sensation. J Hered 1945;36:143-4.
133: Maione L, Benadjaoud S, Eloit C, et al. Computed tomography of the anterior skull base in Kallmann syndrome reveals specific ethmoid bone abnormalities associated with olfactory bulb defects. J Clin Endocrinol Metab 2013;98(3):E537-46. PMID 23348397
134: Males JL, Townsend JL, Schneider RA. Hypogonadotropic hypogonadism with anosmia: Kallmann's syndrome. Arch Intern Med 1973;131:501-7. PMID 4540668
135: Manara R, Brotto D, Bugin S, et al. Rhinencephalon changes in tuberous sclerosis complex. Neuroradiology 2018;60(8):813-20. PMID 29909560
136: Marlier L, Gaugler C, Astruc D, Messer J. The olfactory sensitivity of the premature newborn [Article in French]. Arch Pediatr 2007;14(1):45-53. PMID 17046221
137: Martin LP, Pérez MM, García EG, et al. Atypical case of congenital maxillomandibular fusion with duplication of the craniofacial midline. Craniomaxillofac Trauma Reconstr 2011;4:113-20. PMID 22655122
138: Masaoka Y, Satoh H, Akai L, Homma I. Expiration: the moment we experience retronasal olfaction in flavour. Neurosci Lett 2010;473(2):92-6. PMID 20171264
139: Matsumoto S, Yamazaki C, Masumoto KH, et al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineeticin receptor PKR2. Proc Natl Acad Sci USA 2006;103:4140-5. PMID 16537498
140: Mennella JA, Johnson A, Beauchamp GK. Garlic ingestion by pregnant women alters the odor of amniotic fluid. Chem Senses 1995;20(2):207-9. PMID 7583013
141: Mihalj D, Borbelyova V, Pirnik Z, et al. Shank3 deficiency results in a reduction in GABAergic postsynaptic puncta in the olfactory brain areas. Neurochem Res 2024;49(4):1008-16. PMID 38183586
142: Mizuguchi R, Naritsuka H, Mori K, Yoshihara Y. Tbr2 deficiency in mitral and tufted cells disrupts excitatory-inhibitory balance of neural circuitry in the mouse olfactory bulb. J Neurosci 2012;32:8831-44. PMID 22745484
143: Mori T, Onimaru R, Onodera S, et al. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography. Rad Oncol 2015;10:88. PMID 25888953
144: Mouly AM, Di Scala G. Entorhinal cortex stimulation modulates amygdala and piriform cortex responses to olfactory bulb inputs in the rat. Neuroscience 2006;137(4):1131-41. PMID 16325349
145: Muccioli L, Sighinolfi G, Mitolo M, et al. Cognitive and functional connectivity impairment in post-COVID-19 olfactory dysfunction. Neuroimage Clin 2023;38:103410. PMID 37104928
146: Myers KA, Bello-Espinosa LE, Kherani A, Wei XC, Innes AM. TUBA1A mutation associated with eye abnormalities in addition to brain malformation. Pediatr Neurol 2015;53(5):442-4. PMID 26294046
147: Nakashima T, Kimmelman CP, Snow JB Jr. Structure of human fetal and adult olfactory epithelium. Arch Otolaryngol 1984;110(10):641-6. PMID 6477257
148: Naruse I, Keino H. Induction of agenesis of the corpus callosum by the destruction of anlage of the olfactory bulb using fetal laser surgery exo utero in mice. Dev Brain Res 1993;71:69-74. PMID 8432001
149: Naruse I, Ueta E. Hydrocephalus manifestation in the genetic polydactyly/arhinencephaly mouse (Pdn/Pdn). Congenit Anom (Kyoto) 2002;42(1):27-31. PMID 12094077
150: Novo A, Guerra IC, Rocha F, et al. Kallmann syndrome in a female adolescent: a new mutation in the FGFR1 gene. BMJ Case Rep 2012;2012. PMID 22751423
151: Ohsawa S, Hamada S, Kuida K, et al. Maturation of the olfactory sensory neurons by Apaf-1/caspase-9-mediated caspase activity. Proc Natl Acad Sci USA 2010;107:13366-71. PMID 20624980
152: Okumura A, Hayashi M, Tsurui H, et al. Lissencephaly with marked ventricular dilatation, agenesis of corpus callosum, and cerebellar hypoplasia caused by TUBA1A mutation. Brain Dev 2013;35(3):274-9. PMID 22633752
153: Oliveira LM, Seminara SB, Beranova M, et al. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J Clin Endocrinol Metab 2001;86(4):1532-8. PMID 11297579
154: Palmer AM, Degano AL, Park MJ, et al. Normal mitral cell dendritic development in the setting of Mecp2 mutation. Neuroscience 2012;202:108-16. PMID 22138506
155: Panigrahy A, Lee V, Ceschin R, et al. Brain dysplasia associated with ciliary dysfunction in infants with congenital heart disease. J Pediatr 2016;178:141-8. PMID 27574995
156: Pantazopoulos H, Boyer-Boiteau A, Holbrook EH, et al. Proteoglycan abnormalities in olfactory epithelium tissue from subjects diagnosed with schizophrenia. Schizophr Res 2013;150(2-3):366-72. PMID 24035561
157: Pearson A. The development of the olfactory nerve in man. J Comp Neurol 1941;75:199-217.
158: Penfield W, Jasper H. Epilepsy and the functional anatomy of the human brain. Boston: Little Brown, 1954.
159: Pinar H, Tatevosyants N, Singer DB. Central nervous system malformations in a perinatal/neonatal autopsy series. Pediatr Dev Pathol 1998;1(1):42-8. PMID 10463270
160: Pingault V, Bodereau V, Baral V, et al. Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness. Am J Hum Genet 2013;92(5):707-24. PMID 23643381
161: Pinto G, Abadie V, Mesnage R, et al. CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development. J Clin Endocrinol Metab 2005;90(10):5621-6. PMID 16030162
162: Poo C, Agarwal G, Nonacchi N, Maknen ZF. Spatial maps in piriform cortex during olfactory navigation. Nature 2022;601:595-9. PMID 34937941
163: Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir JY. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 2011;69(5):811-8. PMID 21246603
164: Pourmorady AD, Bashkirova EV, Chiariello AM, et al. RNA-mediated symmetry breaking enables singular olfactory receptor choice. Nature 2024;625(7993):181-8. PMID 38123679
165: Pozzati E, Martinoni M, Marucci G, Bacci A. Olfactory neuroblastoma and olfactory ventricle. A case report. Neuroradiol J 2014;2(4):452-5. PMID 25196619
166: Prager D, Braunstein GD. X-chromosome linked with Kallmann's syndrome: pathology at the molecular level [editorial]. J Clin Endocrinol Metab 1993;76:824-6. PMID 8473390
167: Prosser HM, Bradley A, Caldwell MA, et al. Olfactory bulb hypoplasia in Prokr2 null mice stems from defective neuronal progenitor migration and differentiation. Eur J Neurosci 2007;26:3339-44. PMID 18052978
168: Puelles L, Harrison M, Paxinos G, Watson C. A developmental ontology for the mammalian brain based on the prosomeric model. Trends Neurosci 2013;36(10):570-8. PMID 23871546
169: Pyatkina GA. Development of the olfactory epithelium in man. Z Mikrosk Anat Forsch 1982;96(2):361-72. PMID 7113345
170: Quinton R, Cheow HK, Tymms DJ, et al. Kallmann’s syndrome: is it always for life. Clin Endocrinol 1999;50:481-5. PMID 10468907
171: Quinton R, Duke VM, Priyal A, et al. The neuroradiology of Kallmann’s syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab 1996;81:3010-7. PMID 8768867
172: Radyushkin K, Hammerschmidt K, Boretius S, et al. Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav 2009;8:416-25. PMID 19243448
173: Rajapaksha TW, Eimer WA, Bozza TC, Vassar R. The Alzheimer’s β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb. Mol Neurodegener 2011;6:88. PMID 22204380
174: Ramón y Cajal S de. La corteza olfativa del cerebro. Trab d Laborat d Investig Biol 1901;1.
175: Ramón y Cajal S de. L’histologie du système nerveux de l’homme et des vértébrés. Paris: Masson; 1909-1911. Reprinted in English translation, Histology of the Nervous System of Man and Vertebrates. Volume 2. Oxford: Oxford University Press, 1995.
176: Rasmussen SA, Moore CA, Khoury MJ, Cordero JF. Descriptive epidemiology of holoprosencephaly and arhinencephaly in metropolitan Atlanta, 1968-1992. Am J Med Genet 1996;66(3):320-33. PMID 8985495
177: Robain O, Floquet C, Heldt N, Rozenberg F. Hemimegalencephaly: a clinicopathological study of four cases. Neuropathol Appl Neurobiol 1988;14(2):125-35. PMID 3399023
178: Rombaux P, Grandin C, Duprez T. How to measure olfactory bulb volume and olfactory sulcus depth. B-ENT 2009;13(suppl 5):53-60. PMID 20084805
179: Rombaux P, Mouraux A, Bertrand B, Nicolas G, Duprez T, Hummel T. Retronasal and orthonasal olfactory function in relation to olfactory bulb volume in patients with posttraumatic loss of smell. Laryngoscope 2006;116(6):901-5. PMID 16735894
180: Roosenboom J, Hermans R, Lammens F, et al. Olfactory function in patients with nonsyndromic orofacial clefts and their unaffected relatives. Am J Med Genet A 2018;176(11):2375-81. PMID 30345654
181: Rousselot P, Lois C, Álvarez-Buylla A. Embryonic (PSA) N-CAM reveals chains of migrating neuroblasts between the lateral ventricle and the olfactory bulb of adult mice. J Comp Neurol 1994;351(1):51-61. PMID 7896939
182: Rugarli EI, Ballabio A. Kallmann syndrome: from genetics to neurobiology. JAMA 1993;270:2713-6. PMID 8133589
183: Rupp CI. Olfactory function and schizophrenia: an update. Curr Opin Psychiatry 2010;23:97-102. PMID 20051859
184: Sahan MH, Inal M, Muluk NB, Simsek G. Cribriform plate, crista galli, olfactory fossa and septal deviation. Curr Med Imaging Rev 2019;15(3):319-25. PMID 31989883
185: Sánchez-Pérez M, Recio-Rodríguez M, Jiménez de la Pena M, et al. [Radiological findings in congenital anosmia: a case report] [Spanish]. Rev Neurol (Barcelona) 2011;53:87-90. PMID 21720978
186: Sarfati J, Dode C, Young J. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations. Front Horm Res 2010;39:121-32. PMID 20389090
187: Sarnat HB. Olfactory reflexes in the newborn infant. J Pediatr 1978;92:624-6. PMID 633025
188: Sarnat HB. Cerebral Dysgenesis: Embryology and Clinical Expression. New York: Oxford University Press, 1992:206-8.
189: Sarnat HB. Molecular genetic classification of central nervous system malformations. J Child Neurol 2000;21:675-87. PMID 11063082
190: Sarnat HB. Development of olfaction and taste in the human fetus and neonate. In: Polin RA, Fox WW, Abman SH, editors. Fetal and neonatal physiology. 5th edition. Philadelphia: Elsevier, 2016.
191: Sarnat HB. Transitory and vestigial structures of the developing human nervous system. Pediatr Neurol 2021;123:86-101. PMID 34416613
192: Sarnat HB, Flores-Sarnat L. Neuropathologic research strategies in holoprosencephaly. J Child Neurol 2001;16(12):918-31. PMID 11785508
193: Sarnat HB, Flores-Sarnat L. Olfactory development. Part 2. Developmental neuroanatomy and neuropathology. J Child Neurol 2017;32:579-592.
194: Sarnat HB, Flores-Sarnat L. Development of the human olfactory system. In: Doty RL, León-Sarmiento F, editors. Disorders of Taste and Smell. Philadelphia: Elsevier, 2018.
195: Sarnat HB, Flores-Sarnat L. Survey on olfactory testing by pediatric neurologists: Is the olfactory a “true” cranial nerve? J Child Neurol 2020;35(5):317-21.** PMID 31910727
196: Sarnat HB, Flores-Sarnat L, Wei XC. Olfactory development. Part 1. Functional, from fetal perception to adult wine-tasting. J Child Neurol 2017;32(6):566-78. PMID 28424010
197: Sarnat HB, Yu W. Maturation and dysgenesis of the human olfactory bulb. Brain Pathol 2016;26(3):301-18. PMID 26096058
198: Sarnat HB, Yu W. Keratan sulfate proteoglycan: putative template for neuroblast migratory and axonal fascicular pathways and fetal expression in globus pallidus, thalamus and olfactory bulb. J Neuropathol Exp Neurol 2024. [Epub ahead of print] PMID 38950418
199: Sato N, Katsumata N, Kagami M, et al. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. J Clin Endocrinol Metab 2004;89(3):1079-88. PMID 15001591
200: Schaal B. Prenatal and postnatal human olfactory development: influences on cognition and behavior. In: Doty RL, editor. Handbook of Olfaction and Gustation. New Jersey: John Wiley & Sons, 2015.
201: Schaal B, Marlier L, Soussignan R. Olfactory function in the human fetus: evidence from selective neonatal responsiveness to the odor of amniotic fluid. Behav Neurosci 1998;112(6):1438-49. PMID 9926826
202: Schaffer JP. The lateral wall of the cavum nasi in man with special reference to the various developmental stages. J Morphol 1910;21:613-707.
203: Schmidt H, Gour A, Straehle J, et al. Axonal synapse sorting in medial entorhinal cortex. Nature 2017;549(7673):469-75. PMID 28959971
204: Schwankhaus JD, Currie J, Jaffe MJ, et al. Neurologic findings in men with isolated hypogonadotropic hypogonadism. Neurology 1989;39:223-6. PMID 2915793
205: Scotto-Lomassese S, Nissant A, Mota T, et al. Fragile-X mental retardation protein regulates new neuron differentiation in the adult olfactory bulb. J Neurosci 2011;31:2205-15. PMID 21307257
206: Seminara LB, Oliveira LM, Beranova M, et al. Genetics of hypogonadotropic hypogonadism. J Endocrinol Invest 2000;23:560-5.
207: Seo MY, Seok H, Hwang SJ, et al. Trend of olfactory and gustatory dysfunction in COVID-19 patients in a quarantine facility. J Korean Med Sci 2020;35(41):e375. PMID 33107232
208: Shabbaz MA, De Bernardi F, Alatalo A, et al. Mechanistic understanding of the olfactory neuroepithelium involvement leading to short-term anosmia in COVID-19 using the Adverse Outcome Pathway framework. Cells 2022;11(19):3027. PMID 36230989
209: Singh N, Grewal MS, Austin JH. Familial anosmia. Arch Neurol 1970;22:40-4. PMID 5409599
210: Smitka M, Abolmaali N, Witt M, et al. Olfactory bulb ventricles as a frequent finding in magnetic resonance imaging studies of the olfactory system. Neurosciences 2009;162:482-5. PMID 19401222
211: Sparkes RS, Simpson RW, Paulsen CA. Familial hypogonadotropic hypogonadism with anosmia. Arch Intern Med 1968;121:534-8. PMID 5652405
212: Stevenson RJ, Langdon R. A preliminary investigation of olfactory function in olfactory and audidtory-verbal hallucinators with schizophrenia, and normal controls. Cogn Neuropsychiat 2012;17:315-33. PMID 22181045
213: Stevenson RJ, Mehmut MK, Horstmann A, Hummel T. The aetiology of olfactory dysfunction and its relationship to diet quality. Brain Sci 2020;10(11):769. PMID 33114032
214: Subramanian S, Rajan DS, Gaesser J, Lo CWY, Panigrahy A. Olfactory bulb and olfactory tract abnormalities in acrocallosal syndrome and Greig cephalopolysyndactyly syndrome. Pediatr Radiol 2019;49(10):1368-73. PMID 31399769
215: Sunohara N, Sakuragawa N, Satoyoshi E, et al. A new syndrome of anosmia, ichthyosis, hypogonadism and various neurological manifestations with deficiency of steroid sulfatase and arylsulfatase C. Ann Neurol 1986;19:174-81. PMID 3516063
216: Suspitsin EN, Imyanitov EN. Bardet-Biedl syndrome. Mol Syndromol 2016;7(2):62-71. PMID 27385962
217: Swanson LW. Neuroanatomical terminology. Oxford, NY: Oxford University Press, 2015.
218: Szymkowicz DB, Sims KC. Schwendingeer KL, et al. Exposure to arsenic during embryogenesis impairs olfactory sensory neuron differentiation and function into adulthood. Toxicology 2019;420:73-84. PMID 30978373
219: Tan CJ, Tan BKJ, Liu HT, et al. Neuroradiological basis of COVID-19 olfactory dysfunction: a systematic review and meta-analysis. Laryngoscope 2022;132(6):1260-74. PMID 35318656
220: Tasci I, Balgetir F, Müngen B, Gönen M. Epileptic olfactory auras: a clinical spectrum. Neurol Sci 2021;42(8):3397-401. PMID 33428053
221: Teixeira L, Guimiot F, Dodé, et al. Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditions. J Clin Invest 2010;120:3668-72. PMID 20940512
222: Tobin VA, Hashimoto H, Wacker DW, et al. An intrinsic vasopressin system in the olfactory bulb is involved in social recognition. Nature 2010;464:413-7. PMID 20182426
223: Trapp W, Hei A, Röder S, Wimmer F, Hajak G. “Mmmh, smells like coffee!”– How a brief odor identification trest could help to identify people with mild cognitive impairment and dementia. Brain Sci 2023;13(7):1052. PMID 37508984
224: Truwit CL, Barkovich J, Grunbach MM, Martini JJ. MR imaging of Kallmann syndrome, a genetic disorder of neuronal migration affecting the olfactory and genital systems. Am J Neuroradiol 1993;14:827-37. PMID 8352153
225: Tsutsumi S, Shimizu Y, Nonaka Y, et al. Arteriovenous fistula arising from the persistent primitive olfactory artery with dual supply from the bilateral anterior ethmoidal arteries. Neurol Med Chir (Tokyo) 2009;49:407-9. PMID 19779285
226: Turetsky BI, Crutchley P, Walker J, et al. Depth of the olfactory sulcus: a marker of early embryonic disruption in schizophrenia. Schizophr Res 2009;115:8-11. PMID 19767178
227: Turetsky BI, Moberg PJ, Arnold SE, Doty RL, Gur RE. Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am J Psychiatry 2003;160(4):703-8. PMID 12668359
228: Uchino A, Saito N, Kozawa E, et al. Persistent primitive olfactory artery: MR angiographic diagnosis. Surg Radiol Anat 2011;33:197-201. PMID 21061008
229: Uemura N, Ueda J, Yoshihara T, et al. α-synuclean spread from olfactory bulb causes hyposmia, anxiety and memory loss in BAC-SNCA mice. Mov Disord 2021;36(9):2016-47. PMID 33547846
230: Ueta E, Maekawa M, Morimoto I, Nanba E, Naruse I. Sonic hedgehog expression in Gli3 depressed mouse embryo, Pdn/Pdn. Congenit Anom (Kyoto) 2004;44(1):27-32. PMID 15008897
231: Ueta E, Nanba E, Naruse I. Integration of a transposon into the Gli3 gene in the Pdn mouse. Congenit Anom (Kyoto) 2002;42(4):318-22. PMID 12634451
232: Vaid S, Shah D, Rawat S, Shukla R. Proboscis lateralis with ipsilateral sinonasal and olfactory pathway aplasia. J Pediatr Surg 2010;45:453-6. PMID 20152374
233: Venegas JP, Navarrete M, Orellana-García L, Rojas M, Avello-Duarte F, Nunez-Parra A. Basal forebrain modulation of olfactory coding in vivo. Psychol Res (Medellin) 2023;16(2):62-86. PMID 38106956
234: Venneman W, Van Nie CJ, Tibboel D. Developmental abnormalities of the olfactory bulb: a comparative teratological and experimental study of the pig and chick embryo. Teratology 1982;26(1):65-70. PMID 7135260
235: Vergano-Vera E, Yusta-Boyo MJ, de Castro F, Bernad A, de Pablo F, Vicario-Abejon C. Generation of GABAergic and dopaminergic interneurons from endogenous embryonic olfactory bulb precursor cells. Development 2006;133(21):4367-79. PMID 17038521
236: Veyseller B, Ozucer B, Degirmenci N, et al. Olfactory bulb volume and olfactory function after radiotherapy in patients with nasopharyngeal cancer. Auris Nasus Larynx 2014;41(5):436-40. PMID 24746667
237: Wei G, Gu J, Gu Z, et al. Olfactory dysfunction in patients with coronavirus disease 2019: a review. Front Neurol 2022;12:783249. PMID 35115994
238: White BJ, Rogol AD, Brown KS, et al. The syndrome of anosmia with hypogonadotropic hypogonadism: a genetic study of 18 new families and a review. Am J Med Genet 1983;15:417-35. PMID 6881209
239: Wilson DA, Peterson J, Basavaraj BS, Saiato M. Local and regional network function in behaviorally relevant cortical circuits of adult lmice following alcohol exposure. Alcohol Clin Exp Res 2011;35(11):1974-84. PMID 21649667
240: Wise JB, Moonis G, Mirza N. Magnetic resonance imaging findings in the evaluation of traumatic anosmia. Ann Otol Rhino Laryngol 2006;115(2):124-7. PMID 16514795
241: Yamaguchi K, Honma K. An acardiac twin with advanced development of the brain: a histologic and volumetric study. Clin Neuropathol 2014;33(1):84-90. PMID 24040763
242: Yamaguchi K, Shimizu K, Suzumura H. Short rib-polydactyly syndrome: lethal chondrodysplasia associated with brain malformations in a 35-week-gestation infant. Clin Neuropathol 2006;25(3):128-33. PMID 16719409
243: Yamamoto T, Suzuki K, Yamazaki T, et al. Persistent primitive olfactory artery aneurysm. Neurol Med Chir (Tokyo) 2009;49:303-5. PMID 19633402
244: Yoo HS, Jeon S, Chung SJ, et al. Olfactory dysfunction in Alzheimer’s disease- and Lewy body-related cognitive impairment. Alzheimers Dement 2018;14(10):1243-52. PMID 29936148
245: Youngentob SL, Kent PF, Younentob LM. Gestational naltrexone ameliorates fetal ethanol exposures enhancing effect on the postnatal behavioural and neural response to ethanol. Exp Biol Med 2012;237(10):1197-208. PMID 23045720
246: Yousem DM, Geckle RJ, Bilker W, et al. MR evaluation of patients with congenital hyposmia or anosmia. Am J Radiol 1996;166:439-43. PMID 8553963
247: Yousem DM, Turner WJD, Li C, et al. Kallmann syndrome: MR evaluation of olfactory system. Am J Neuroradiol 1993;14:839-43. PMID 8352154
248: Yousry I, Camelio S, Schmid UD, et al. Visualization of cranial nerves I-XII: value of 3D CISS and T2-weighted FSE sequences. Eur Radiol 2000;10(7):1061-7. PMID 11003398
249: Zenaty D, Bretones P, Lambe C, et al. Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1). Mol Cell Endocrinol 2006;254-5:78-83. PMID 16757108

Patient Profile

Age range of presentation: 0 month to 65+ years
Sex preponderance: male>female, >2:1
Heredity: heredity may be a factor

heredity typical

X-linked

autosomal dominant

autosomal recessive
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-10: Other congenital anomalies of brain: Q04
ICD-11: Gonadotropin deficiency: 5A61.2

Hypoplasia or agenesis of cerebellar hemispheres: LA06.1
OMIM: Kallmann syndrome 1: #308700

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Olfactory bulb agenesis, hypoplasias, and dysplasias

Associated Disorders

Agenesis of the corpus callosum
Autism
Cerebellar dysfunction
CHARGE syndrome
Congenital heart disease
- Diabetes mellitus
- Disorders of eye movement
- Hearing impairment
- Hemimegalencephaly
- Holoprosencephaly
- Hypogonadotropic hypogonadism with anosmia
- Ichthyosis
- Kleefstra syndrome
- Lissencephaly of TUBA1A mutation
- Mental handicap
- Pes cavus
- Rubinstein-Taybi syndrome
- Schizophrenia
- Supernumerary olfactory bulbs
- Synkinesis
- Trisomy 13
- Tuberous sclerosis complex
- Waardenburg syndromes
- Weaver syndrome

Olfactory bulb agenesis, hypoplasias, and dysplasias

Olfactory bulb agenesis, hypoplasias, and dysplasias

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Outcomes

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

X-linked hydrocephalus (L1 syndrome)

Neurogenetics and genetic and genomic testing

Acute traumatic spinal cord injury

Tumors of the skull base

Toxic and nutritional deficiency optic neuropathies

Cerebro-oculo-facio-skeletal syndrome

Nystagmus

Third nerve palsy

Olfactory bulb agenesis, hypoplasias, and dysplasias

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Outcomes

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

X-linked hydrocephalus (L1 syndrome)

Neurogenetics and genetic and genomic testing

Acute traumatic spinal cord injury

Tumors of the skull base

Toxic and nutritional deficiency optic neuropathies

Cerebro-oculo-facio-skeletal syndrome

Nystagmus

Third nerve palsy

This is an article preview.
Start a Free Account
to access the full version.